Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT03635190
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 112 participants
- Sponsor
- Cardio Flow, Inc.
- Registry
-
NCT03635190
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03635190. Allocation not applicable; no masking; primary purpose treatment. Start 2018-12-17 (actual); primary completion 2021-03-24 (actual). Results posted on 2022-11-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
- Acronym
- FASTII
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Orbital Circumferential Atherectomy
- Lead sponsor
- Cardio Flow, Inc.
- Collaborator
- Libra Medical
Record details
- Record id
cardio:ct-nct03635190- Content hash
c7412e1df23a459b60955d4c3f6008a8c8949f77025939cefee8adb0eacd5382